The global age-related macular degeneration (AMD) market reached a revenue of $5.3 billion in 2015 and it is predicted to attain a value of $8.9 billion by 2022. Furthermore, the market will demonstrate a CAGR of 7.6% from 2016 to 2022 (forecast period), as per the estimates of the market research firm, P&S Intelligence. The market is being driven by the increasing incidence of chronic diseases, surging healthcare expenditure in several countries, soaring pipeline of AMD drugs, and…

According to the World Health Organization, approximately 1.1 billion people smoke tobacco, and the number would double by 2050, if nothing is done. Tobacco consumption, apart from leading to lung cancer and other respiratory diseases, is the most-significant reason behind the development and progression of age-related macular degeneration (AMD). A chronic eye disease, AMD damages the macula of the retina, thereby leading to blurred vision and often a blind spot in the visual…

A number of factors such as the surging aging female population, increasing prevalence of infertility cases, and soaring incidence of uterine malformations are expected to drive the female fertility and pregnancy rapid test market at a CAGR of 4.5% during the forecast period (2016–2022). Moreover, the rising adoption of at-home diagnostic devices and mounting awareness about pregnancy and fertility among females will also help the market in generating a revenue of $489.3 million by…